|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 05738307.7 (espacenet) (Federated) (European Patent Register), 20050415 | | Patent/reg. no. and date | DK/EP 1763356, 20080716 | | Publication date | 20070321 | | Priority no. and date | US 564540 P, 20040422 | | EP pub. no. and date |
EP 1763356 20070321 | | Effective date | | | Applicant/owner | ELI LILLY AND COMPANY, Lilly Corporate Center
Indianapolis, Indiana 46285, US | | Applicant ref. no. | P80827949DK00E | | Inventor | PATEL, Bharvin, Kumar, 14255 Esprit Drive
Westfield, IN 46074, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 31/7068 (2006.01) , A61K 31/7088 (2006.01) , A61P 35/00 (2006.01) | | Title | Sammensætning der omfatter et survivinantisenseoligonuckleotid og gemcitabin til behandling af cancer | | Int. application no. | US2005012968 | | Int. publication no. | WO2005107771 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
